Cost‐Effectiveness of Strategies Used in the Evaluation of Pregnancies Complicated by Elevated Maternal Serum Alpha‐Fetoprotein Levels

[1]  D. Waller,et al.  Fetal Karyotyping for Chromosome Abnormalities After an Unexplained Elevated Maternal Serum Alpha‐Fetoprotein Screening , 1995, Obstetrics and gynecology.

[2]  F. Vavelidis,et al.  Elevated maternal serum α-fetoprotein levels: What is the risk of fetal ancuploidy?☆ , 1995 .

[3]  L. Godmilow,et al.  Ultrasound‐Adjusted Risk and Spectrum of Fetal Chromosomal Abnormality in Women With Elevated Maternal Serum Alpha‐Fetoprotein , 1995, Obstetrics and gynecology.

[4]  F. K. Ennever,et al.  PARENT PREFERENCES AND PRENATAL TESTING FOR NEURAL TUBE DEFECTS , 1995, Epidemiology.

[5]  R. Goldstein,et al.  Alpha-fetoprotein screening programs: what every obstetric sonologist should know. , 1993, Radiology.

[6]  A. Robinson,et al.  Prognosis of prenatally diagnosed children with sex chromosome aneuploidy. , 1992, American journal of medical genetics.

[7]  J. Canick,et al.  Prenatal screening for Down's syndrome with use of maternal serum markers. , 1992, The New England journal of medicine.

[8]  R. Filly,et al.  The California Maternal Serum alpha-Fetoprotein Screening Program: the role of ultrasonography in the detection of spina bifida. , 1992, American journal of obstetrics and gynecology.

[9]  D. Nyberg,et al.  Cesarean section before the onset of labor and subsequent motor function in infants with meningomyelocele diagnosed antenatally , 1991, The New England journal of medicine.

[10]  L. Holmes,et al.  Absence of need for amniocentesis in patients with elevated levels of maternal serum alpha-fetoprotein and normal ultrasonographic examinations. , 1990, The New England journal of medicine.

[11]  J. Hobbins,et al.  Elevated Maternal Serum Alpha-Fetoprotein Concentration and Fetal Chromosomal Abnormalities , 1990, Obstetrics and gynecology.

[12]  B. Burton,et al.  Risk of fetal chromosomal anomalies in patients with elevated maternal serum alpha‐fetoprotein , 1990, Obstetrics and gynecology.

[13]  N. Wald,et al.  Amniotic fluid acetylcholinesterase measurement in the prenatal diagnosis of open neural tube defects. Second report of the collaborative acetylcholinesterase study , 1989, Prenatal diagnosis.

[14]  M. Maresh,et al.  Maternal Fetal Medicine. Principles and Practice , 1989 .

[15]  J. Haddow,et al.  Second‐Trimester Maternal Serum Alpha‐Fetoprotein Levels in Pregnancies Associated With Gastroschisis and Omphalocele , 1988, Obstetrics and gynecology.

[16]  J. Philip,et al.  Incidence of fetal chromosome abnormalities in 2264 low‐risk women , 1987, Prenatal diagnosis.

[17]  M C Weinstein,et al.  Use and misuse of the term "cost effective" in medicine. , 1986, The New England journal of medicine.

[18]  E. Hook,et al.  Chromosomal abnormality rates at amniocentesis and in live-born infants. , 1983, JAMA.

[19]  M. Seabright,et al.  KARYOTYPING AMNIOTIC FLUIDS FROM PATIENTS WITH HIGH SERUM ALPHA-FETOPROTEIN , 1981, The Lancet.

[20]  C. Gosden,et al.  Prenatal fetal karyotyping and maternal serum alpha-fetoprotein screening. , 1981, British medical journal.

[21]  Hook Eb,et al.  Prenatal screening for neural tube defects and chromosome abnormalities: the complexities of program evaluation. , 1995 .

[22]  N. Chescheir,et al.  The role of ultrasound in evaluation of patients with elevated maternal serum alpha-fetoprotein: a review. , 1991, Obstetrics and gynecology.

[23]  Peter W. Callen,et al.  Ultrasonography in Obstetrics and Gynecology , 1983 .

[24]  J. Simpson,et al.  The prenatal diagnosis of genetic disorders. , 1982, Clinical obstetrics and gynecology.

[25]  J. Milunsky,et al.  Genetic Disorders and the Fetus , 1988 .